Jarvi E T, McCarthy J R, Mehdi S, Matthews D P, Edwards M L, Prakash N J, Bowlin T L, Sunkara P S, Bey P
Merrell Dow Research Institute, Cincinnati, Ohio 45215.
J Med Chem. 1991 Feb;34(2):647-56. doi: 10.1021/jm00106a028.
The design and synthesis of (E)- and (Z)-5'-fluoro-4',5'-didehydro-5'-deoxyadenosine (6 and 13, respectively), a new class of mechanism-based inhibitors of S-adenosyl-L-homocysteine (SAH) hydrolase, is described. A number of analogues of 6 and 13 were synthesized in order to determine the structure-activity relationship necessary for inhibition of the enzyme. Substitution of chlorine for fluorine in 6 (i.e. 44), addition of an extra chlorine to the 5'-vinyl position (i.e. 51 and 52), modification of the 2'-hydroxyl group to the deoxy (34 and 35) and arabino (36 and 37) nucleosides provided competitive inhibitors of SAH hydrolase. Nucleosides 6 and 13, as well as 5'-deoxy-5',5'-difluoroadenosine (14) proved to be time-dependent inhibitors of SAH hydrolase. All three compounds are postulated to inhibit through the potent electrophile derived from oxidation of the 3'-hydroxyl of 6 or 13 to the ketone (i.e. 3 and/or the E-isomer). Consistent with the proposed mechanism of inactivation of SAH hydrolase by 6, 13, and 14 was the observation that incubation of purified rat liver SAH hydrolase with 6 resulted in release of 1 equiv of fluoride ion (by 19F NMR) and incubation with 14 resulted in release of 2 equiv of fluoride ion. The general synthetic route developed for the synthesis of the title nucleosides utilized the fluoro Pummerer reaction for the introduction of fluorine into the requisite precursors. Preliminary antiretroviral data from Moloney leukemia virus (MoLV) is presented and correlates with SAH hydrolase inhibition. Antiviral activity (IC50 against MoLV) ranged from 0.05 to 10 micrograms/mL.
描述了一类新型的基于机制的S-腺苷-L-高半胱氨酸(SAH)水解酶抑制剂——(E)-和(Z)-5'-氟-4',5'-二脱氢-5'-脱氧腺苷(分别为6和13)的设计与合成。合成了6和13的多种类似物,以确定抑制该酶所需的构效关系。在6中用氯取代氟(即44)、在5'-乙烯基位置添加一个额外的氯(即51和52)、将2'-羟基修饰为脱氧(34和35)及阿拉伯糖(36和37)核苷,得到了SAH水解酶的竞争性抑制剂。核苷6和13以及5'-脱氧-5',5'-二氟腺苷(14)被证明是SAH水解酶的时间依赖性抑制剂。据推测,所有这三种化合物都是通过将6或13的3'-羟基氧化为酮(即3和/或E-异构体)衍生的强亲电试剂来抑制。与6、13和14使SAH水解酶失活的拟议机制一致的是,观察到用6孵育纯化的大鼠肝脏SAH水解酶会释放1当量的氟离子(通过19F NMR),用14孵育会释放2当量的氟离子。为合成标题核苷开发的通用合成路线利用氟代Pummerer反应将氟引入所需的前体中。给出了来自莫洛尼白血病病毒(MoLV)的初步抗逆转录病毒数据,且这些数据与SAH水解酶抑制相关。抗病毒活性(对MoLV的IC50)范围为0.05至10微克/毫升。